[
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "Aldurazyme (laronidase)",
    "disease_indication": [
      "Mucopolysaccharidosis Type I (MPS I)"
    ],
    "development_phase": "Approved",
    "moa": "Enzyme Replacement Therapy",
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH_wBgGHMiNTTvbsthlasqS21KX3xvUMoRr7NT-Qn5UF_gYWieVmqitYallz1u02-5wqrQN3O5nfwtb-JJ0arwDSH2SYz9JD9eqsHGqWSGNjaEQbms043t0Y_70l5Gbts1AsNPpfLZtUtVMjVsqF6Ef"
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "Brineura (cerliponase alfa)",
    "disease_indication": [
      "Batten disease (CLN2 disease)"
    ],
    "development_phase": "Approved",
    "moa": "Enzyme Replacement Therapy",
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH_wBgGHMiNTTvbsthlasqS21KX3xvUMoRr7NT-Qn5UF_gYWieVmqitYallz1u02-5wqrQN3O5nfwtb-JJ0arwDSH2SYz9JD9eqsHGqWSGNjaEQbms043t0Y_70l5Gbts1AsNPpfLZtUtVMjVsqF6Ef"
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "Firdapse (amifampridine phosphate)",
    "disease_indication": [
      "Lambertâ€“Eaton myasthenic syndrome (LEMS)"
    ],
    "development_phase": "Approved",
    "moa": null,
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH_wBgGHMiNTTvbsthlasqS21KX3xvUMoRr7NT-Qn5UF_gYWieVmqitYallz1u02-5wqrQN3O5nfwtb-JJ0arwDSH2SYz9JD9eqsHGqWSGNjaEQbms043t0Y_70l5Gbts1AsNPpfLZtUtVMjVsqF6Ef"
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "Kuvan (sapropterin dihydrochloride)",
    "disease_indication": [
      "Phenylketonuria (PKU)"
    ],
    "development_phase": "Approved",
    "moa": null,
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH_wBgGHMiNTTvbsthlasqS21KX3xvUMoRr7NT-Qn5UF_gYWieVmqitYallz1u02-5wqrQN3O5nfwtb-JJ0arwDSH2SYz9JD9eqsHGqWSGNjaEQbms043t0Y_70l5Gbts1AsNPpfLZtUtVMjVsqF6Ef"
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "Naglazyme (galsulfase)",
    "disease_indication": [
      "Mucopolysaccharidosis Type VI (MPS VI)"
    ],
    "development_phase": "Approved",
    "moa": "Enzyme Replacement Therapy",
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH_wBgGHMiNTTvbsthlasqS21KX3xvUMoRr7NT-Qn5UF_gYWieVmqitYallz1u02-5wqrQN3O5nfwtb-JJ0arwDSH2SYz9JD9eqsHGqWSGNjaEQbms043t0Y_70l5Gbts1AsNPpfLZtUtVMjVsqF6Ef"
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "Palynziq (pegvaliase-pqpz)",
    "disease_indication": [
      "Phenylketonuria (PKU)"
    ],
    "development_phase": "Approved",
    "moa": null,
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFT4CeaSpWajJ4J6ymoVr6PycfaR84T1SSuhiclYZNsHG0EtT80Prvik8jNh-xle8YFk7e0BHK4lUtC7uH6czW9Lr_OVdqmTZ2t6i31OVu7DDkNTeQ="
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "Palynziq (pegvaliase-pqpz)",
    "disease_indication": [
      "Phenylketonuria (PKU) in adolescents aged 12-17"
    ],
    "development_phase": "Approved",
    "moa": null,
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFT4CeaSpWajJ4J6ymoVr6PycfaR84T1SSuhiclYZNsHG0EtT80Prvik8jNh-xle8YFk7e0BHK4lUtC7uH6czW9Lr_OVdqmTZ2t6i31OVu7DDkNTeQ="
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "Roctavian (valoctocogene roxaparvovec)",
    "disease_indication": [
      "Severe Hemophilia A"
    ],
    "development_phase": "Approved",
    "moa": "Gene Therapy",
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHuLU690AA5Ypo4gKlEM8ga0DAvNySH-56xpMhvW_Dzbb5Ef0IanHpa8rwDfmY7RcU62wrdpXtcHr3UYwUPlpuSwUUWfh0iz-elkMB3KX5OLFYQoOqywQdZtMV2j5FZk7IyOos-Fc3vLtscihri-NKH9_8P6TVGf2zXUOl-hbiRq_9tP587Ld8rvLm33AYiQpA4ZdhqBciwBwtcyrPvIR0XoJxePFw="
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "Vimizim (elosulfase alfa)",
    "disease_indication": [
      "Morquio A Syndrome (MPS IVA)"
    ],
    "development_phase": "Approved",
    "moa": "Enzyme Replacement Therapy",
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH_wBgGHMiNTTvbsthlasqS21KX3xvUMoRr7NT-Qn5UF_gYWieVmqitYallz1u02-5wqrQN3O5nfwtb-JJ0arwDSH2SYz9JD9eqsHGqWSGNjaEQbms043t0Y_70l5Gbts1AsNPpfLZtUtVMjVsqF6Ef"
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "Voxzogo (vosoritide)",
    "disease_indication": [
      "Achondroplasia"
    ],
    "development_phase": "Approved",
    "moa": null,
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHuLU690AA5Ypo4gKlEM8ga0DAvNySH-56xpMhvW_Dzbb5Ef0IanHpa8rwDfmY7RcU62wrdpXtcHr3UYwUPlpuSwUUWfh0iz-elkMB3KX5OLFYQoOqywQdZtMV2j5FZk7IyOos-Fc3vLtscihri-NKH9_8P6TVGf2zXUOl-hbiRq_9tP587Ld8rvLm33AYiQpA4ZdhqBciwBwtcyrPvIR0XoJxePFw="
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "Voxzogo (vosoritide)",
    "disease_indication": [
      "Hypochondroplasia"
    ],
    "development_phase": "Phase III",
    "moa": null,
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.google.com/grounding-api-redirect/AUZIYQGkoPPx4xUSECSDnia1-Wk1ZMZVlxiWafkkvF7Gu84AWRL_edG6epNGBS4oN8J3AQlU4A23TVOkaLRZX2HMgDKapJ5rf98Fb0PAKaGVvJ9pdCZNyC7G0qB1zmX_R0tGkcx6OLekHTGF8e_lFyyS6vhP0PsJtvr60sPY1bke"
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "BMN 333",
    "disease_indication": [
      "Achondroplasia",
      "Hypochondroplasia",
      "Growth Disorders"
    ],
    "development_phase": "Phase I",
    "moa": "Long-acting C-type Natriuretic Peptide (CNP)",
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEWNwM-XeKkKc6HniX-mFQ0GRkFmF8mLhbA0LYIGITjzgQWThG8SXxo3t5gHTmqB2Mv4sAerVTAih0a52s1Y60Hkl-RVKY0q0rQxU9t66EYU-qnutlIktsNNo4heA7la7w-IGlHAa0C4puag42sscaEq-cDIZNQ532gglZtUvMBPvr0scYUOd7lLJDnH0mCQBCFzDlEBPJeVC-NhBf27NPADzlGbezTPioszuiCFfKuBanWw1MBjg=="
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "BMN 349",
    "disease_indication": [
      "Alpha-1 Antitrypsin Deficiency (AATD)-associated liver disease"
    ],
    "development_phase": "Phase I",
    "moa": "Alpha-1 Antitrypsin (A1AT) modulator, protein folding stabilizer (molecular chaperone)",
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGqupxCMaMG2rt0tGyfiM_XXr9Hw7nilWyHlBmV23Lbi8UbMQdGIdJBauX924tR_l1wOB7EuKzoDfD3Q0pO2La2WL5XoRj8KC1teWMm3pgH-hvDb8Tpzgziqjupo4bj02vK6saRMX6SHWHKpwVEzGUQPHvuyODt8Ua9XPrYx0YCdIUL7weoEHo9Dlp3vDLApNYRmCO9vYQ2lLs_dk8LX-6WH6YKWCHu8UGzMWhKGtCIU1hoVamHR9NryAslvrFd"
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "BMN 351",
    "disease_indication": [
      "Duchenne Muscular Dystrophy (Exon 51 skipping amenable)"
    ],
    "development_phase": "Phase I",
    "moa": "Next-generation oligonucleotide (Exon skipping therapy)",
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEWNwM-XeKkKc6HniX-mFQ0GRkFmF8mLhbA0LYIGITjzgQWThG8SXxo3t5gHTmqB2Mv4sAerVTAih0a52s1Y60Hkl-RVKY0q0rQxU9t66EYU-qnutlIktsNNo4heA7la7w-IGlHAa0C4puag42sscaEq-cDIZNQ532gglZtUvMBPvr0scYUOd7lLJDnH0mCQBCFzDlEBPJeVC-NhBf27NPADzlGbezTPioszuiCFfKuBanWw1MBjg=="
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "BMN 401",
    "disease_indication": [
      "ENPP1 Deficiency"
    ],
    "development_phase": "Phase I",
    "moa": "First-in-class therapy",
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEWNwM-XeKkKc6HniX-mFQ0GRkFmF8mLhbA0LYIGITjzgQWThG8SXxo3t5gHTmqB2Mv4sAerVTAih0a52s1Y60Hkl-RVKY0q0rQxU9t66EYU-qnutlIktsNNo4heA7la7w-IGlHAa0C4puag42sscaEq-cDIZNQ532gglZtUvMBPvr0scYUOd7lLJDnH0mCQBCFzDlEBPJeVC-NhBf27NPADzlGbezTPioszuiCFfKuBanWw1MBjg=="
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "BMN 255",
    "disease_indication": [
      "Metabolic dysfunction-associated steatohepatitis (MASH)"
    ],
    "development_phase": "Phase I",
    "moa": null,
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHuLU690AA5Ypo4gKlEM8ga0DAvNySH-56xpMhvW_Dzbb5Ef0IanHpa8rwDfmY7RcU62wrdpXtcHr3UYwUPlpuSwUUWfh0iz-elkMB3KX5OLFYQoOqywQdZtMV2j5FZk7IyOos-Fc3vLtscihri-NKH9_8P6TVGf2zXUOl-hbiRq_9tP587Ld8rvLm33AYiQpA4ZdhqBciwBwtcyrPvIR0XoJxePFw="
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "BMN 293",
    "disease_indication": [
      "MYBPC3 hypertrophic cardiomyopathy"
    ],
    "development_phase": "Preclinical",
    "moa": "Gene therapy",
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEYWVp4tp7OoJa5jF8E34gKeFi8uMqg3EqK-y0a2WxG_JroBH6A5TKuzC7Uxg9eIsBll9yj6MJzxewM_ugysKcZAzWDch92r1EGqgU_4PSkoY8mYI9ZvZKxbjTBJl34_c_560yRlJEnqYR1-SbUXIXe1w22iS5LtWaIcx-p3STdBPpdFWSNDc85Yu3zZ2GK4mdBjzl1A45oUCDFtloXh0G6ITt_sxG2D7bosCdcgRlQVjnmdN-xNw=="
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "BMN 331",
    "disease_indication": [
      "Hereditary angioedema"
    ],
    "development_phase": "Phase I",
    "moa": "Gene therapy",
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHuLU690AA5Ypo4gKlEM8ga0DAvNySH-56xpMhvW_Dzbb5Ef0IanHpa8rwDfmY7RcU62wrdpXtcHr3UYwUPlpuSwUUWfh0iz-elkMB3KX5OLFYQoOqywQdZtMV2j5FZk7IyOos-Fc3vLtscihri-NKH9_8P6TVGf2zXUOl-hbiRq_9tP587Ld8rvLm33AYiQpA4ZdhqBciwBwtcyrPvIR0XoJxePFw="
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "BMN 355",
    "disease_indication": [
      "Long-QT syndrome types 2 and 3"
    ],
    "development_phase": "Preclinical",
    "moa": "Monoclonal antibody",
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHuLU690AA5Ypo4gKlEM8ga0DAvNySH-56xpMhvW_Dzbb5Ef0IanHpa8rwDfmY7RcU62wrdpXtcHr3UYwUPlpuSwUUWfh0iz-elkMB3KX5OLFYQoOqywQdZtMV2j5FZk7IyOos-Fc3vLtscihri-NKH9_8P6TVGf2zXUOl-hbiRq_9tP587Ld8rvLm33AYiQpA4ZdhqBciwBwtcyrPvIR0XoJxePFw="
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "BMN 365",
    "disease_indication": [
      "Plakophilin-2 mutations and arrhythmogenic right ventricular dysplasia/cardiomyopathy"
    ],
    "development_phase": "Preclinical",
    "moa": null,
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHuLU690AA5Ypo4gKlEM8ga0DAvNySH-56xpMhvW_Dzbb5Ef0IanHpa8rwDfmY7RcU62wrdpXtcHr3UYwUPlpuSwUUWfh0iz-elkMB3KX5OLFYQoOqywQdZtMV2j5FZk7IyOos-Fc3vLtscihri-NKH9_8P6TVGf2zXUOl-hbiRq_9tP587Ld8rvLm33AYiQpA4ZdhqBciwBwtcyrPvIR0XoJxePFw="
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "BMN 390",
    "disease_indication": [
      "Phenylketonuria (PKU)"
    ],
    "development_phase": "Preclinical",
    "moa": null,
    "route_of_admin": null,
    "status": null,
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGkoPPx4xUSECSDnia1-Wk1ZMZVlxiWafkkvF7Gu84AWRL_edG6epNGBS4oN8J3AQlU4A23TVOkaLRZX2HMgDKapJ5rf98Fb0PAKaGVvJ9pdCZNyC7G0qB1zmX_R0tGkcx6OLekHTGF8e_lFyyS6vhP0PsJtvr60sPY1bke"
    ]
  }
]